Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Ownership

$36.68

north_east $0.26 (0.71%)
Day's range
$36.03
Day's range
$37.27

Biohaven Pharmaceutical Holding Company Ltd. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/13/2024 7.79 M $389.06 M   7.07% 8.25%
BLACKROCK FUNDING, INC. /DE 11/13/2024 6.88 M $343.66 M   100.00% 7.29%
STIFEL FINANCIAL CORP 11/14/2024 6.51 M $325.27 M   0.44% 6.90%
JANUS HENDERSON GROUP PLC 11/14/2024 6.23 M $311.14 M   5.56% 6.60%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2024 5.20 M $259.80 M   0.00% 5.51%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2024 3.64 M $182.02 M   62.04% 3.86%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 3.44 M $171.82 M   4.69% 3.64%
STATE STREET CORP 11/14/2024 3.26 M $162.73 M   -10.78% 3.45%
RP MANAGEMENT, LLC 11/13/2024 2.94 M $146.74 M   0.00% 3.11%
BELLEVUE GROUP AG 11/14/2024 2.04 M $101.98 M   0.00% 2.16%
FMR LLC 11/13/2024 1.84 M $92.00 M   -0.71% 1.95%
CITADEL ADVISORS LLC 11/14/2024 1.76 M $87.70 M   -6.49% 1.86%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.71 M $85.70 M   2.64% 1.82%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 1.50 M $74.97 M   745.89% 1.59%
PERCEPTIVE ADVISORS LLC 11/14/2024 1.49 M $74.22 M   0.00% 1.57%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2024 1.48 M $74.08 M   -22.52% 1.57%
ARMISTICE CAPITAL, LLC 11/14/2024 1.20 M $59.94 M   -14.14% 1.27%
REDMILE GROUP, LLC 11/14/2024 1.03 M $51.68 M   -4.91% 1.10%
ARS INVESTMENT PARTNERS, LLC 10/16/2024 1.03 M $51.48 M   9.54% 1.09%
BROWN ADVISORY INC 11/13/2024 968,359 $48.39 M   100.00% 1.03%
WOODLINE PARTNERS LP 11/14/2024 923,807 $46.16 M   14.46% 0.98%
HOOD RIVER CAPITAL MANAGEMENT LLC 11/14/2024 902,888 $45.12 M   144.75% 0.96%
HOLOCENE ADVISORS, LP 11/14/2024 852,627 $42.61 M   -49.74% 0.90%
JPMORGAN CHASE & CO 12/26/2024 809,448 $40.45 M   85.35% 0.86%
VOYA INVESTMENT MANAGEMENT LLC 11/14/2024 710,979 $35.53 M   9.12% 0.75%
ORACLE INVESTMENT MANAGEMENT INC 11/14/2024 705,250 $35.24 M   0.69% 0.75%
CAPITAL INTERNATIONAL INVESTORS 11/13/2024 671,414 $33.55 M   0.00% 0.71%
GOLDMAN SACHS GROUP INC 11/14/2024 642,376 $32.10 M   -11.90% 0.68%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 632,690 $31.62 M   5.46% 0.67%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 592,599 $29.61 M   1.28% 0.63%
D. E. SHAW & CO., INC. 11/14/2024 577,723 $28.87 M   6.90% 0.61%
MORGAN STANLEY 11/14/2024 563,877 $28.18 M   -21.55% 0.60%
AMERICAN CENTURY COMPANIES INC 11/12/2024 510,475 $25.51 M   -0.15% 0.54%
VESTAL POINT CAPITAL, LP 11/14/2024 500,000 $24.99 M   100.00% 0.53%
CLEARBRIDGE INVESTMENTS, LLC 11/12/2024 479,249 $23.95 M   -0.03% 0.51%
5AM VENTURE MANAGEMENT, LLC 11/14/2024 478,972 $23.93 M   1.92% 0.51%
AVIDITY PARTNERS MANAGEMENT LP 11/14/2024 465,000 $23.24 M   3.33% 0.49%
CORMORANT ASSET MANAGEMENT, LP 11/14/2024 401,963 $20.09 M   -49.88% 0.43%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2024 399,827 $19.98 M   -37.00% 0.42%
MARSHALL WACE, LLP 11/14/2024 371,669 $18.57 M   252.07% 0.39%
VICTORY CAPITAL MANAGEMENT INC 11/05/2024 363,615 $18.17 M   67.06% 0.39%
AMERIPRISE FINANCIAL INC 11/14/2024 363,351 $18.16 M   38.08% 0.39%
BISON WEALTH, LLC 11/05/2024 330,988 $16.54 M   0.87% 0.35%
IKARIAN CAPITAL, LLC 11/14/2024 325,600 $16.27 M   100.00% 0.35%
FIRST TURN MANAGEMENT, LLC 11/07/2024 315,816 $15.78 M   -13.72% 0.33%
TD ASSET MANAGEMENT INC 11/01/2024 310,842 $15.85 M   5.07% 0.33%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 307,069 $15.34 M   128.24% 0.33%
SIREN, L.L.C. 11/13/2024 283,540 $14.17 B   100.00% 0.30%
TWO SIGMA INVESTMENTS, LP 11/14/2024 280,765 $14.03 M   -16.93% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 275,800 $13.78 M   156.32% 0.29%

Biohaven Pharmaceutical Holding Company Ltd.institutional Ownership - FAQ's

Who are the largest shareholders of BHVN shares?

During the previous two years, 318 institutional investors and hedge funds held shares of Biohaven Pharmaceutical Holding Company Ltd.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 7.79 M

BlackRock Funding, Inc. /DE: 6.88 M

STIFEL FINANCIAL CORP: 6.51 M

JANUS HENDERSON GROUP PLC: 6.23 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 5.2 M

FARALLON CAPITAL MANAGEMENT LLC: 3.64 M

What percentage of Biohaven Pharmaceutical Holding Company Ltd. stock is owned by institutional investors?

90.49% of Biohaven Pharmaceutical Holding Company Ltd. stock is owned by institutional investors.

How much institutional buying is happening at BHVN ?

Institutional investors have bought a total of 98.01 M shares in the last 24 months. This purchase volume represents approximately $3.60 B in transactions.